Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
DisGeNET
DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
| Source | Last Updated |
|---|---|
| DisGeNET | July 29, 2024 |
| Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▲ | UniProt ID |
|---|---|---|---|---|---|
| C0007102 | Malignant tumor of colon | ULBP2 | 80328 | UL16 binding protein 2 | Q9BZM5 |
| C0235974 | Pancreatic carcinoma | ULBP2 | 80328 | UL16 binding protein 2 | Q9BZM5 |
| C0007115 | Malignant neoplasm of thyroid | ULBP2 | 80328 | UL16 binding protein 2 | Q9BZM5 |
| C0699790 | Colon Carcinoma | ULBP2 | 80328 | UL16 binding protein 2 | Q9BZM5 |
| C0006826 | Malignant Neoplasms | ULBP2 | 80328 | UL16 binding protein 2 | Q9BZM5 |
| C1306459 | Primary malignant neoplasm | ULBP2 | 80328 | UL16 binding protein 2 | Q9BZM5 |
| C1332986 | Childhood Osteosarcoma | ULBP2 | 80328 | UL16 binding protein 2 | Q9BZM5 |
| C0346647 | Malignant neoplasm of pancreas | ULBP2 | 80328 | UL16 binding protein 2 | Q9BZM5 |
| C0023467 | Leukemia, Myelocytic, Acute | ULBP2 | 80328 | UL16 binding protein 2 | Q9BZM5 |
| C0238461 | Anaplastic thyroid carcinoma | ULBP2 | 80328 | UL16 binding protein 2 | Q9BZM5 |
| C0035335 | Retinoblastoma | ULBP2 | 80328 | UL16 binding protein 2 | Q9BZM5 |
| C0026764 | Multiple Myeloma | ULBP2 | 80328 | UL16 binding protein 2 | Q9BZM5 |
| C0206698 | Cholangiocarcinoma | VTCN1 | 79679 | V-set domain containing T cell activation inhibitor 1 | Q7Z7D3 |
| C0015934 | Fetal Growth Retardation | VTCN1 | 79679 | V-set domain containing T cell activation inhibitor 1 | Q7Z7D3 |
| C1306459 | Primary malignant neoplasm | VTCN1 | 79679 | V-set domain containing T cell activation inhibitor 1 | Q7Z7D3 |
| C0346647 | Malignant neoplasm of pancreas | VTCN1 | 79679 | V-set domain containing T cell activation inhibitor 1 | Q7Z7D3 |
| C0027651 | Neoplasms | VTCN1 | 79679 | V-set domain containing T cell activation inhibitor 1 | Q7Z7D3 |
| C0007137 | Squamous cell carcinoma | VTCN1 | 79679 | V-set domain containing T cell activation inhibitor 1 | Q7Z7D3 |
| C0006142 | Malignant neoplasm of breast | VTCN1 | 79679 | V-set domain containing T cell activation inhibitor 1 | Q7Z7D3 |
| C1332977 | Childhood Leukemia | VTCN1 | 79679 | V-set domain containing T cell activation inhibitor 1 | Q7Z7D3 |
| C4048328 | cervical cancer | VTCN1 | 79679 | V-set domain containing T cell activation inhibitor 1 | Q7Z7D3 |
| C0302592 | Cervix carcinoma | VTCN1 | 79679 | V-set domain containing T cell activation inhibitor 1 | Q7Z7D3 |
| C0678222 | Breast Carcinoma | VTCN1 | 79679 | V-set domain containing T cell activation inhibitor 1 | Q7Z7D3 |
| C1140680 | Malignant neoplasm of ovary | VTCN1 | 79679 | V-set domain containing T cell activation inhibitor 1 | Q7Z7D3 |
| C0278878 | Adult Glioblastoma | VTCN1 | 79679 | V-set domain containing T cell activation inhibitor 1 | Q7Z7D3 |
